Third-line treatment in metastatic renal cell carcinoma and bone metastases

被引：0
|
作者：
Heng, Daniel Y. C. [1 ]
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2015年 / 9卷 / 7-8期
关键词：
D O I：
10.5489/cuaj.3238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [41] Intraoperative Cryotherapy in the Treatment of Metastatic Renal Cell Carcinoma of the Bone
    Sundet, Alec
    McConnell, Jodi
    Walker, Kyle
    Lindeque, Bennie
    ORTHOPEDICS, 2021, 44 (05) : E645 - E652
  • [42] Third-Line Therapy in Metastatic Colorectal Cancer
    van de Haar, Joris
    Valeri, Nicola
    Voest, Emile E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 190 - 191
  • [43] Third-line therapy for metastatic colorectal cancer
    M. G. Gundgaard
    J. B. Soerensen
    E. Ehrnrooth
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 1 - 13
  • [44] Third-line therapy for metastatic colorectal cancer
    Gundgaard, M. G.
    Soerensen, J. B.
    Ehrnrooth, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 1 - 13
  • [45] Erratum to: Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization
    Germano Scevola
    Giorgio Loreni
    Marco Rastelli
    Stefano Sposato
    Sara Ramponi
    Vittorio Miele
    Medical Oncology, 2017, 34
  • [46] CRYOSURGERY IN TREATMENT OF BONE METASTASES FROM RENAL CELL-CARCINOMA
    MARCOVE, RC
    SEARFOSS, RC
    WHITMORE, WF
    GRABSTALD, H
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1977, (127) : 220 - 227
  • [47] Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
    Matteo Santoni
    Alessandro Conti
    Giuseppe Procopio
    Camillo Porta
    Toni Ibrahim
    Sandro Barni
    Francesco Maria Guida
    Andrea Fontana
    Alfredo Berruti
    Rossana Berardi
    Francesco Massari
    Bruno Vincenzi
    Cinzia Ortega
    Davide Ottaviani
    Giacomo Carteni
    Gaetano Lanzetta
    Delia De Lisi
    Nicola Silvestris
    Maria Antonietta Satolli
    Elena Collovà
    Antonio Russo
    Giuseppe Badalamenti
    Stefano Luzi Fedeli
    Francesca Maria Tanca
    Vincenzo Adamo
    Evaristo Maiello
    Roberto Sabbatini
    Alessandra Felici
    Saverio Cinieri
    Rodolfo Montironi
    Sergio Bracarda
    Giuseppe Tonini
    Stefano Cascinu
    Daniele Santini
    Journal of Experimental & Clinical Cancer Research, 34
  • [48] Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
    Santoni, Matteo
    Conti, Alessandro
    Procopio, Giuseppe
    Porta, Camillo
    Ibrahim, Toni
    Barni, Sandro
    Guida, Francesco Maria
    Fontana, Andrea
    Berruti, Alfredo
    Berardi, Rossana
    Massari, Francesco
    Vincenzi, Bruno
    Ortega, Cinzia
    Ottaviani, Davide
    Carteni, Giacomo
    Lanzetta, Gaetano
    De Lisi, Delia
    Silvestris, Nicola
    Satolli, Maria Antonietta
    Collova, Elena
    Russo, Antonio
    Badalamenti, Giuseppe
    Fedeli, Stefano Luzi
    Tanca, Francesca Maria
    Adamo, Vincenzo
    Maiello, Evaristo
    Sabbatini, Roberto
    Felici, Alessandra
    Cinieri, Saverio
    Montironi, Rodolfo
    Bracarda, Sergio
    Tonini, Giuseppe
    Cascinu, Stefano
    Santini, Daniele
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [49] Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review
    Chan, Wing-lok
    Lam, Ka-on
    So, Tsz-him
    Lee, Victor Ho-fun
    Kwong, Lai-wan Dora
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [50] Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Lin, Sue-Hwa
    Satcher, Robert L.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul G.
    Tannir, Nizar M.
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 363 - 370
12345